» Articles » PMID: 17996637

Cognitive/behavioral Teratogenetic Effects of Antiepileptic Drugs

Overview
Journal Epilepsy Behav
Date 2007 Nov 13
PMID 17996637
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

The majority of children of mothers with epilepsy are normal, but they are at increased risk for developmental delay. Antiepileptic drugs (AEDs) appear to play a role. Our current knowledge is reviewed, including research design issues and recommendations for future research. In animals, exposure of the immature brain to some AEDs can produce widespread neuronal apoptosis and behavioral deficits. The risks of AEDs in humans are less clear, but recent studies raise concerns, especially for valproate. There is a critical need for well-designed systematic research to improve our understanding of AED effects on the fetal brain.

Citing Articles

Comparison of the effect of phenobarbital & levetiracetam in the treatment of neonatal abstinence syndrome (NAS) as adjuvant treatment in neonates admitted to the neonatal intensive care unit: a randomized clinical trial.

Jamali Z, Molaei-Farsangi M, Ahmadipour H, Bahmanbijari B, Sabzevari F, Parizi Z BMC Pregnancy Childbirth. 2024; 24(1):242.

PMID: 38580935 PMC: 10996075. DOI: 10.1186/s12884-024-06433-y.


Present in the Aquatic Environment, Unclear Evidence in Top Predators-The Unknown Effects of Anti-Seizure Medication on Eurasian Otters () from Northern Germany.

Rohner S, Gramer M, Wiesweg I, Scherf-Clavel O, Wohlsein P, Schmelz M Toxics. 2023; 11(4).

PMID: 37112566 PMC: 10142713. DOI: 10.3390/toxics11040338.


Neurocognitive Effects of Antiseizure Medications in Children and Adolescents with Epilepsy.

Besag F, Vasey M Paediatr Drugs. 2021; 23(3):253-286.

PMID: 33956338 DOI: 10.1007/s40272-021-00448-0.


Risk of early neurodevelopmental disorders associated with in utero exposure to valproate and other antiepileptic drugs: a nationwide cohort study in France.

Coste J, Blotiere P, Miranda S, Mikaeloff Y, Peyre H, Ramus F Sci Rep. 2020; 10(1):17362.

PMID: 33093466 PMC: 7581762. DOI: 10.1038/s41598-020-74409-x.


Neurocognition after prenatal levetiracetam, lamotrigine, carbamazepine or valproate exposure.

Huber-Mollema Y, van Iterson L, Oort F, Lindhout D, Rodenburg R J Neurol. 2020; 267(6):1724-1736.

PMID: 32112258 PMC: 7293688. DOI: 10.1007/s00415-020-09764-w.


References
1.
Manthey D, Asimiadou S, Stefovska V, Kaindl A, Fassbender J, Ikonomidou C . Sulthiame but not levetiracetam exerts neurotoxic effect in the developing rat brain. Exp Neurol. 2005; 193(2):497-503. DOI: 10.1016/j.expneurol.2005.01.006. View

2.
Ikonomidou C, Bittigau P, Koch C, Genz K, Hoerster F, Felderhoff-Mueser U . Neurotransmitters and apoptosis in the developing brain. Biochem Pharmacol. 2001; 62(4):401-5. DOI: 10.1016/s0006-2952(01)00696-7. View

3.
Wide K, Henning E, Tomson T, Winbladh B . Psychomotor development in preschool children exposed to antiepileptic drugs in utero. Acta Paediatr. 2002; 91(4):409-14. DOI: 10.1080/080352502317371643. View

4.
Kini U, Adab N, Vinten J, Fryer A, Clayton-Smith J . Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes. Arch Dis Child Fetal Neonatal Ed. 2005; 91(2):F90-5. PMC: 2672688. DOI: 10.1136/adc.2004.067421. View

5.
Pizzi W, Alexander T, Loftus J . Developmental and behavioral effects of prenatal primidone exposure in the rat. Pharmacol Biochem Behav. 1996; 55(4):481-7. DOI: 10.1016/s0091-3057(96)00247-x. View